Research Paper Volume 11, Issue 16 pp 6286—6311

Efficacy and safety of neoadjuvant chemotherapy regimens for triple-negative breast cancer: a network meta-analysis

class="figure-viewer-img"

Figure 6. Stochastic multi-criteria acceptability analysis for benefit-risk. (A) Rank probability of regimens based on synthesizing pCR and anemia. (B) Rank probability of regimens based on synthesizing pCR and neutropenia. (C) Rank probability of regimens based on synthesizing pCR and thrombocytopenia. (D) Rank probability of regimens based on synthesizing pCR and the three serious adverse events. Rank 1 represents the best treatment and rank N represents the worst. The proportion corresponds to the probability of each regimen to be at a specific rank.